TB
Triana Biomedicines, Inc.
SEC filingPharmaceuticals · Lexington, MA
Amount raised$120.1Msold at filing
Total offering$120.1M
Investors in the raise20count reported to the SEC
FiledDec 4, 2025first sale Nov 26, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Patrick TrojerExecutive Officer, Director
Joshua ResnickDirector
Jigar RaythathaDirector
David GrayzelDirector
Andrew HedinDirector
Lorence KimDirector
Shelley ChuDirector
Christopher O'DonnellDirector
Executive officers, directors and promoters as listed on the Form D.